Abstract
Purpose
Lung volume reduction surgery (LVRS) has been shown to improve lung function, but also improve the overall quality of life (QOL). The aim of this study is to compare two QOL questionnaires-EuroQol Questionnaire (EQ-5D-3L) and 36-item Short Form Health Survey (SF-36) in patients post-LVRS.
Methods
All patients undergoing LVRS for severe chronic obstructive pulmonary disease (COPD) at a single center of excellence were analyzed (n = 94). Baseline demographic and clinical outcomes were characterized. Both EQ-5D-3L and SF-36 questionnaires were administered to all patients at baseline (n = 94) and at the end of 1 year (n = 89) post-surgery. SF-36 was converted to Short Form six-dimensions (SF-6D) using standard algorithm. Correlation, discrimination, responsiveness and differences across the two questionnaires were examined.
Results
The mean age of patients enrolled in the cohort was 66 years. There was significant increase in forced expiratory volume (FEV1, 43%), forced vital capacity (FVC 46%), diffusion capacity (DLCO 15%), 6 min walk distance test (6MWD 21%) and a significant decrease in residual volume (RV 23%) at the end of 1-year follow-up. The overall mean utility index significantly improved for both SF-6D and EQ-5D-3L questionnaires at the end of follow-up (p = 0.0001). However, the magnitude of percentage increase was higher with EQ-5D-3L compared to SF-6D (32% vs. 13%). Stronger correlations confirmed convergent validity at the end of 1-year follow-up between similar domains. Both questionnaires failed to discriminate between different levels of disease severity post-LVRS in patients with severe COPD.
Conclusions
Both questionnaires responded similarly in patients with COPD post-LVRS. Combining results from QOL questionnaire(s) along with symptoms of disease and history of exacerbation may be a possible solution for identifying disease severity in old and sick patients unwilling/unable to come to hospital for a pulmonary function test post-LVRS.
Similar content being viewed by others
References
Centers for Disease Control and Prevention. (2012). Chronic obstructive pulmonary disease among adults–United States, 2011. Morbidity and Mortality Weekly Report, 61(46), 938–943.
Wheaton, A. G., Cunningham, T. J., Ford, E. S., Croft, J. B., Centers for Disease C., & Prevention (2015). Employment and activity limitations among adults with chronic obstructive pulmonary disease–United States, 2013. Morbidity and Mortality Weekly Report, 64(11), 289–295.
Centers for Diseasr Control and Prevention. (2017). Chronic obstructive pulmonary disease. Retrieved May 31, 2018, from https://www.cdc.gov/copd/index.html#6.
Wacker, M. E., Jorres, R. A., Karch, A., Wilke, S., Heinrich, J., Karrasch, S., Koch, A., Schulz, H., Watz, H., Leidl, R., Vogelmeier, C., Holle, R., & Consortium, C. (2016). Assessing health-related quality of life in COPD: Comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulmonary Medicine, 16(1), 70.
Goldstein, R. S., Todd, T. R., Guyatt, G., Keshavjee, S., Dolmage, T. E., van Rooy, S., Krip, B., Maltais, F., LeBlanc, P., Pakhale, S., & Waddell, T. K. (2003). Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 58(5), 405–410.
Huang, W., Wang, W. R., Deng, B., Tan, Y. Q., Jiang, G. Y., Zhou, H. J., & He, Y. (2011). Several clinical interests regarding lung volume reduction surgery for severe emphysema: Meta-analysis and systematic review of randomized controlled trials. Journal of Cardiothoracic Surgery, 6, 148.
Kaplan, R. M., Sun, Q., & Ries, A. L. (2015). Quality of well-being outcomes in the National Emphysema Treatment Trial. Chest, 147(2), 377–387.
Beer, T. M., Miller, K., Tombal, B., Cella, D., Phung, D., Holmstrom, S., Ivanescu, C., Skaltsa, K., & Naidoo, S. (2017). The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies. European Journal of Cancer, 87, 21–29.
Vickers, M. M., Lee, C., Tu, D., Wheatley-Price, P., Parulekar, W., Brundage, M. D., Moore, M. J., Au, H., O’Callaghan, C. J., Jonker, D. J., Ringash, J., & Goldstein, D. (2016). Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3. Pancreatology, 16(6), 1106–1112.
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.
Chen, J., Wong, C. K., McGhee, S. M., Pang, P. K., & Yu, W. C. (2014). A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS ONE, 9(11), e112389.
Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236.
McCrone, P., Patel, A., Knapp, M., Schene, A., Koeter, M., Amaddeo, F., Ruggeri, M., Giessler, A., Puschner, B., & Thornicroft, G. (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. The Journal of Mental Health Policy and Economics, 12(1), 27–31.
Pickard, A. S., Yang, Y., & Lee, T. A. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9, 26.
Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53–72.
Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.
Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.
User’s Manual for the Medical Outcomes Study (MOS). (1995). Core measures of health-related quality of life. Santa Monica: RAND Corporation.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.
Global Initiative for COPD. (2017). Pocket guide to COPD diagnosis, management, and prevention: A guide for health care professionals.
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3), 837–845.
Vestbo, J., Hurd, S. S., & Rodriguez-Roisin, R. (2012). The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)—why and what? The Clinical Respiratory Journal, 6(4), 208–214.
Moayeri, F., Hsueh, Y. S., Clarke, P., Hua, X., & Dunt, D. (2016). Health state utility value in chronic obstructive pulmonary disease (COPD); the challenge of heterogeneity: A systematic review and meta-analysis. COPD, 13(3), 380–398.
van Stel, H. F., & Buskens, E. (2006). Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes, 4, 20.
Ringbaek, T., Brondum, E., Martinez, G., & Lange, P. (2008). EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respiratory Medicine, 102(11), 1563–1567.
Kularatna, S., Byrnes, J., Chan, Y. K., Ski, C. F., Carrington, M., Thompson, D., Stewart, S., & Scuffham, P. A. (2017). Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. Quality of Life Research, 26(12), 3399–3408.
Rowen, D., Young, T., Brazier, J., & Gaugris, S. (2012). Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health, 15(8), 1059–1068.
Brazier, J., Rowen, D., Tsuchiya, A., Yang, Y., & Young, T. A. (2011). The impact of adding an extra dimension to a preference-based measure. Social Science & Medicine, 73(2), 245–253.
Payakachat, N., Ali, M. M., & Tilford, J. M. (2015). Can The EQ-5D detect meaningful change? A Systematic Review. Pharmacoeconomics, 33(11), 1137–1154.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Research involving in animal participants
This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Thuppal, S., Markwell, S., Crabtree, T. et al. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS). Qual Life Res 28, 1885–1892 (2019). https://doi.org/10.1007/s11136-019-02123-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-019-02123-x